Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Research puts use of skin surface temperature scans to detect COVID-19 into question

Research puts use of skin surface temperature scans to detect COVID-19 into question

Stories May 21, 2021 4 minutes
Research puts use of skin surface temperature scans to detect COVID-19 into question

New findings show that limitations of infrared thermography make it an unreliable COVID-19 detection tool.

Walk into an airport or mall these days and you might be scanned by an infrared thermography (IRT) camera. Used to generate a heat map of infrared radiation emitted by heat sources, such as body temperature, IRT has become a go-to for the mass detection of illnesses, such as COVID-19.

The limitations of this technology are revealed in new research findings published in the Journal of Medical Imaging in March 2021. Led by Vancouver Coastal Health Research Institute researcher Dr. Babak Shadgan, the study concluded that IRT relies too heavily on detecting high fever, which is only one of several symptoms of an active and well-developed COVID-19 infection. 

As of April 2021, COVID-19 had claimed the lives of over three million people worldwide. Around 55.5 per cent of confirmed COVID-19 infections involved fever. This leaves almost half of infected individuals under IRT’s radar.

Underlying health conditions, stress, pregnancy, certain medications and other environmental factors, such as temperature and humidity, can also alter someone’s surface body temperature. This can result in a false positive or false negative IRT reading, says Shadgan.

“Many people who contract the virus will be asymptomatic for the first five days, while others may not present with fever at all.”

Shadgan’s research reviewed 17 published studies on the effectiveness of IRT screening at airports around the world between 2002 and 2021.

He found that the non-contact thermometer’s ability to detect SARS, dengue fever, swine flu, Ebola and COVID-19 varied significantly.

Low camera quality, very low sensitivity to true body temperature and an inability to detect asymptomatic patients were the main reasons for the shortfall, which sometimes amounted to a complete failure to detect active disease. 

"Since the 2003 SARS outbreak, infrared thermal cameras have been installed in countries around the world, including Canada, Taiwan and Australia.”

“Screening is important for being able to detect and diagnose disease as soon as possible,” says Shadgan, who will be deciding how best to screen for COVID-19 among participating athletes and their support personnel as the medical director of the 2021 Tokyo Olympic Games wrestling competitions. “Yet our findings show that IRT frequently missed patients with active disease.”

Early detection helps prevent viral spread through early diagnosis, says Shadgan. This in turn supports the best possible prognosis, which can translate into reduced health care costs when symptoms that could lead to hospitalization and long-term health effects are nipped in the bud. 

Dr. Babak Shadgan is the director of the ICORD Clinical Biophotonics Laboratory, an assistant professor in the Department of Orthopaedics, an associate in the School of Biomedical Engineering and an associate in the Department of Pathology and Laboratory Medicine at the University of British Columbia.

However, Shadgan admits that, until a better rapid, non-invasive and affordable detection method becomes available, IRT will likely continue to be part of the disease detection toolkit.

“I would say that IRT can continue to be used if there is no other option, but we should not rely entirely on its results. IRT is only really effective at detecting individuals who are symptomatic with a high fever. It does not detect asymptomatic individuals or infected individuals with only a slight rise in body temperature.”

Multiple methods recommended for improved detection

Given its limitations, IRT has sometimes been paired with pulse oximetry in an effort to improve disease detection. Pulse oximetry uses a fingertip sensor to detect oxygen saturation in a person’s bloodstream. Oxygen levels below 95 per cent are found among people with pneumonia—another symptom of a severe COVID-19 infection.

Shadgan’s research indicates that “screening other vital signs, such as heart and respiratory rates, could lead to more robust methods for early infection detection.”

Core body temperature is also a more accurate indicator of a COVID-19 infection, notes Shadgan. The limitations of present screening tools do, however, pose a challenge. For example, IRT can only map a person’s surface body temperature.

To address this, Shadgan is developing a novel biosensor to take COVID-19 disease detection a step further. The non-invasive, simple-to-use and accurate biosensing device—which earned him a COVID-19 Wall Solutions award—could be used for regular and routine COVID-19 screening and early diagnosis.

“This novel biosensing screening process will initially be geared towards early detection of COVID-19 among high-risk individuals, specifically those living in long-term care facilities.”

“Individuals with underlying health conditions, such as heart or liver disease, immune deficiency, diabetes or cancer, could use the biosensor on a regular basis to check whether they have COVID-19 symptoms,” says Shadgan. “This technology would support self-monitoring among the most vulnerable individuals in our community.”
 

Researchers

Babak Shadgan

Related Articles

Sniffing sleuths: Canine disease detectives

Heath care priority management post-COVID-19

COVID-19 linked to changes in the brain

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

International Collaboration on Repair Discoveries

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy